.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Ticlopidine hydrochloride - Generic Drug Details

« Back to Dashboard
Ticlopidine hydrochloride is the generic ingredient in two branded drugs marketed by Watson Labs, Mylan, Sandoz, Sun Pharm Inds Inc, Teva, Actavis Elizabeth, Roche Palo, and Apotex, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for ticlopidine hydrochloride. Three suppliers are listed for this compound.

Summary for Generic Name: ticlopidine hydrochloride

Tradenames:2
Patents:0
Applicants:8
NDAs:10
Drug Master File Entries: see list9
Suppliers / Packaging: see list3
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: ticlopidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991DISCNNo► subscribe► subscribe
Apotex
TICLOPIDINE HYDROCHLORIDE
ticlopidine hydrochloride
TABLET;ORAL075089-001Jul 1, 1999RXNo► subscribe► subscribe
Teva
TICLOPIDINE HYDROCHLORIDE
ticlopidine hydrochloride
TABLET;ORAL075149-001Aug 20, 1999RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ticlopidine hydrochloride

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 19934,051,141► subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 19914,591,592► subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 19914,051,141► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc